Searched for
SALIX PHARMACEUTICALS
Alembic Pharma jumps over 6% on getting approval from USFDA for Mesalamine extended-release capsules“The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Apriso Extended-Release Capsules, 0.375 g, of ...- Alembic Pharma receives final approval from USFDA for generic Mesalamine extended-release capsulesThe approved drug is therapeutically equivalent to Salix Pharmaceuticals Inc's reference listed drug (RLD), Apriso extended-release capsule...
- Glenmark Pharma gets USFDA nod for diabetes management drug"Glenmark Pharmaceuticals Inc, USA, has been granted final approval by the United States Food & Drug Administration (USFDA) for metformin h...
- Valeant to sell $2.1 billion in assets to pay down debtSkincare is the largest category in the cosmetics industry, accounting for more than one-third of the global market, according to data trac...
- Lupin gets FDA nod to market ulcerative colitis tablets in USThe company has received tentative approval to market its Balasalazide Disodium tablets 1.1 gm from the United States Food and Drug Adminis...
- Lupin launches anti-bacterial Zaxine tablets in CanadaZaxine 550 mg (rifaximin) is a long-term antibiotic treatment drug for adults living with HE, a complication of liver disease (cirrhosis).
- Pharma in 2014: Deals worth billions and fines worth millionsRanbaxy, founded by the family of Malvinder and Shivinder Mohan Singh, was at the centre of most of the developments for major part of the ...
- Continuously evaluating opportunities for tie-ups with large MNCs: Ramesh Swaminathan, Lupin'We do keep talking to various big pharma companies for various kinds of alliance. So potentially I cannot speak about any deal until it ac...
- Glenmark US partner Salix gets USFDA nod for Crofelemer tabletUS Food and Drug Administration provided marketing approval to its partner in US, Salix Pharmaceuticals, for Crofelemer 125 mg delayed-rele...
- USFDA approves Glenmark’s anti-diarrheal drug; stock gainsShares of Glenmark Pharma gained momentum following the FDA approval to Salix Pharma for marketing Crofelemer.
- Glenmark Pharmaceuticals to initiate filing for Crofelemer as Salix submits NDAGlenmark is going full steam ahead with the launch of Crofelemer post the issue of Napo Pharma's claim of termination of the deal.
- Napo termination will not impact company: GlenmarkIn an interview with ET Now, Glenn Saldanha, Chairman and Managing Director, Glenmark, gives his views on the company's strategies. Excerpt...
- Glenmark files arbitration claim against Napo PharmaceuticalsGlenmark has filed arbitration claims against Napo Pharmaceuticals for ending a contract to develop and market diarrhea drug.
- We anticipate margins between 22% to 23% for the full year: Glenn Saldanha, Glenmark Ltd.Glenn Saldanha, Chairman and Managing Director, Glenmark Ltd., in an interview with ET Now, speaks about the company’s performance in the q...
- Glenmark gets $15 mn plant upgradation advance from SalixGlenmark Pharmaceuticals on Tuesday said it has received USD 15 million (over Rs 65 crore) from Salix Pharmaceuticals Inc, USA.
- Lupin settles patent suit over Solodyn tablets with Medicis, signs R&D agreementDrug maker Lupin said it has settled patent suit with Medicis Pharmaceutical and signed a pact for development of multiple therapeutic comp...
- Glenmark achieves positive results for anti-diarrhoea moleculeGlenmark and Salix have also entered into a commercial supply agreement for Crofelemer active pharmaceutical ingredient.
- Glenmark Pharma: Miles to go before new drug makes a markGlenmark’s partners — US-based Napo Pharmaceuticals and Salix Pharmaceuticals — have announced completion of phase-III trials for the drug ...
- Glenmark moves closer to HIV drug launchGlenmark Pharmaceuticals has completed the third phase of human trials of Crofelemer, a new drug to treat HIV-related diarrhoea that could ...
- Glenmark will launch Crofelemer in ROW countries by 2010Glenmark Pharmaceuticals Ltd has reported new development that should accelerate the launch of Crofelemer.
Load More
